Fundies. English
Psyence Biomedical Ltd.
EDGAR67 filing records in this dataset, filed from 2023-08-01 to 2026-10-05. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 7.44 million USD Source
Exact value
7444763 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-05.
Financial data available through: 2026-03-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- operating income: No compatible figures in this window
- net income: No compatible figures in this window
- Operating cash flow: 4 of 11 periods available· newest 2026-03-31
- Capital expenditure: 3 of 11 periods available· newest 2026-03-31
- Total assets: 3 of 11 periods available· newest 2026-03-31
- Total liabilities: 3 of 11 periods available· newest 2026-03-31
- Current assets: 3 of 11 periods available· newest 2026-03-31
- current liabilities: No compatible figures in this window
- Cash and cash equivalents: 4 of 11 periods available· newest 2026-03-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Operating cash flow
−USD 4.41 millionPrior period
−USD 3.73 million
–
Current period
−USD 8.14 million
–
Exact inputs and evidence
-8143007 − -3734238 = -4408769 USD
-3734238 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source-8143007 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-97.7%Prior period
USD 9,877
–
Current period
USD 229
–
Exact inputs and evidence
229 − 9877 = -9648 USD
9877 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source229 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Net income.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2022-04-01 – 2023-03-31 | Unavailable Not reported for this period. | −USD 1.59 million Exact valueExact value: -1592080 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-04-01 – 2024-03-31 | Unavailable Not reported for this period. | −USD 2.95 million Exact valueExact value: -2945365 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 5,727 Exact valueExact value: 5727 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.95 million Calculation and evidence-2945365 − 5727 USD Exact free cash flow: -2951092 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2024-04-01 – 2025-03-31 | Unavailable Not reported for this period. | −USD 3.73 million Exact valueExact value: -3734238 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 9,877 Exact valueExact value: 9877 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.74 million Calculation and evidence-3734238 − 9877 USD Exact free cash flow: -3744115 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2026 2025-04-01 – 2026-03-31 | Unavailable Not reported for this period. | −USD 8.14 million Exact valueExact value: -8143007 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 229 Exact valueExact value: 229 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.14 million Calculation and evidence-8143007 − 229 USD Exact free cash flow: -8143236 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
67 filings · 842 latest values · 842 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001985062, 1985062, edgar:1985062
Also known as PSYENCE BIOMEDICAL LTD, PSYENCE BIOMEDICAL LTD., Psyence Biomedical Ltd., Psyence Biomedical Ltd.